Clinical Trials in Luoyang

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV

Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19029 matching records held by the registry are in this view. Synced 20 Sep 2026, 17:51 UTC

19029

Studies in scope

all four open statuses

11774

Recruiting now

open to new participants

2008

Lead sponsors

across recruiting studies

Top sites

Beijing 4 Shanghai 3 Luoyang 2 Bengbu 1 Guangzhou 1

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site location

All 17 locations

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

Chinese sites

Start

Active, closed

RBD5044 in Chinese Participants With Hypertriglyceridemia

NCT07587788Hypertriglyceridemia

Ribotek Biopharmaceuticals (Shandong) Co., Ltd

Phase 2

Daqing, Harbin, Luoyang, Jingzhou, Nanyang, Yuncheng, Beijing

2026-02-28

Recruiting

Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

NCT06822790Hypertriglyceridemia

Arrowhead Pharmaceuticals

Phase 3

869

Bengbu, Beijing, Guangzhou, Liuzhou, Xingtai, Luoyang, Changsha, Wuhan

2025-04-09

Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-china/city/luoyang

Query this register directly

GET /api/trials?country=cn&status=recruiting&format=json Try it now →

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.